Dr. Katherine Janeway, MD

• Pediatric Hematology & Oncology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Boston Children's Hospital/dana-farber Cancer Institute, Pediatric Hematology/oncology

  Fellowship Hospital, 2009

• Childrens Hospital

  Internship Hospital, 2001

• Harvard Medical School

  Medical School, 2000

• Phase 2 Study of Anti-Disialoganglioside Antibody, Dinutuximab, in Combination with GM-CSF in Patients with Recurrent Osteosarcoma: A Report from the Children's Oncology Group, 2022-07-06

• The Childhood Cancer Data Initiative: Using the Power of Data to Learn From and Improve Outcomes for Every Child and Young Adult With Pediatric Cancer, 2023-06-02

• Differentiation of NUT Midline Carcinoma by Epigenomic Reprogramming, 2011-03-29

• STRONG EXPRESSION OF IGF1R IN PEDIATRIC GASTROINTESTINAL STROMAL TUMORS WITHOUTIGF1RGENOMIC AMPLIFICATION, 2010-12-01

• Phase 2 Trial of the GPNMB-Targeted Antibody-Drug Conjugate, Glembatumumab Vedotin (CDX-011) in Recurrent Osteosarcoma AOST1521: A Report from the Children's Oncology Group (COG), 2019-10-03

• Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial, 2016-10-01

• Emerging concepts for PI3K/mTOR inhibition as a potential treatment for osteosarcoma [version 1; referees: 2 approved], 2016-07-06

• Identification of Patients With Localized Ewing Sarcoma at Higher Risk for Local Failure: A Report From the Children's Oncology Group, 2017-08-24

• Erratum to ‘Linking EORTC QLQ-C-30 and PedsQL/PEDQOL physical functioning scores in patients with osteosarcoma' [Eur J Cancer 170 (2022) 209-235], 2022-12-01

• Post-Transcriptional Dysregulation by miRNAs Is Implicated in the Pathogenesis of Gastrointestinal Stromal Tumor [GIST], 2013-05-24

• Renal medullary carcinomas depend uponSMARCB1loss and are sensitive to proteasome inhibition, 2019-03-12

• The use of interval-compressed chemotherapy with the addition of vincristine, irinotecan and temozolomide for pediatric patients with newly diagnosed desmoplastic small round cell tumor, 2020-07-19

• Patterns of Translocation Testing in Patients Enrolling in a Cooperative Group Trial for Newly Diagnosed Metastatic Ewing Sarcoma A Report From the Children's Oncology Group, 2021-12-01

• Priorities to Promote Participant Engagement in the Participant Engagement and Cancer Genome Sequencing (PE-CGS) Network, 2023-02-15

• Clinical Trial Enrollment of Adolescents and Young Adults With Sarcoma, 2017-05-11

• Factors Influencing Survival after Recurrence in Osteosarcoma: A Report from the Children's Oncology Group., 2018-09-25

• Charting a Path for Prioritization of Novel Agents for Clinical Trials in Osteosarcoma: a Report from the Children's Oncology Group New Agents for Osteosarcoma Task Force, 2021-06-16

• Matched Targeted Therapy for Pediatric Patients with Relapsed, Refractory or High-risk Leukemias: A Report from the LEAP Consortium, 2021-02-09

• An international working group consensus report for the prioritization of molecular biomarkers for Ewing sarcoma, 2022-09-17

• Future Directions in the Treatment of Osteosarcoma, 2016-02-04

• Genomic Profiling of a Large Set of Diverse Pediatric Cancers Identifies Known and Novel Mutations across Tumor Spectra, 2017-01-09

• Sunitinib in pediatric patients with advanced gastrointestinal stromal tumor: results from a phase I/II trial, 2019-04-20

• Duality of purpose: Participant and parent understanding of the purpose of genomic tumor profiling research among children and young adults with solid tumors, 2019-01-22

• Towards a Drug Development Path that Targets Metastatic Progression in Osteosarcoma, 2014-05-06

• A combination CDK4/6 and IGF1R inhibitor strategy for Ewing sarcoma, 2018-11-05

• Linking EORTC QLQ-C-30 and PedsQL/PEDQOL physical functioning scores in patients with osteosarcoma, 2022-07-01

• Effects of dexrazoxane on doxorubicin-related cardiotoxicity and second malignant neoplasms in children with osteosarcoma: a report from the Children's Oncology Group, 2019-10-28

• A Phase II Study of Eribulin in Recurrent or Refractory Osteosarcoma: a report from the Children's Oncology Group, 2018-10-30

• Correction: Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group, 2019-03-18

• Outcome of Patients with Relapsed or Progressive Ewing Sarcoma Enrolled on Cooperative Group Phase 2 Clinical Trials: a Report from the Children's Oncology Group, 2021-09-08

• Provocative Questions in osteosarcoma basic and translational biology: a report from the Children's Oncology Group, 2019-07-29

• A single-institution pediatric and young adult interventional oncology collaborative: Novel therapeutic options for relapsed/refractory solid tumors, 2023-06-01

• Integrated genetic and pharmacologic interrogation of rare cancers, 2016-06-22

• Comparison of Epidemiology, Clinical Features, and Outcomes of Patients with Reported Ewing Sarcoma and PNET over 40 Years Justifies Current WHO Classification and Treatment Approaches, 2018-08-08

• Canine osteosarcoma genome sequencing identifies recurrent mutations inDMDand the histone methyltransferase geneSETD2, 2019-07-19

• Survey of Paediatric Oncologists and Pathologists regarding Their Views and Experiences with Variant Translocations in Ewing and Ewing-Like Sarcoma: A Report of the Children's Oncology Group, 2020-12-05

• Succinate Dehydrogenase Mutation Underlies Global Epigenomic Divergence in Gastrointestinal Stromal Tumor, 2013-04-02

• Circulating Endothelial Cells and Circulating Endothelial Precursor Cells in Patients with Osteosarcoma, 2011-02-11

• MicroRNA paraffin-based studies in osteosarcoma reveal reproducible independent prognostic profiles at 14q32, 2013-01-22

• Retrospective evaluation of single patient investigational new drug (IND) requests in pediatric oncology, 2021-03-09

• Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort, 2019-03-01

• Impact of Two Measures of Micrometastatic Disease on Clinical Outcomes in Patients with Newly Diagnosed Ewing Sarcoma: A Report from the Children's Oncology Group, 2016-02-09

• Linsitinib (OSI-906) for the treatment of Adult and Pediatric Wild Type Gastrointestinal Stromal Tumors, a SARC Phase II study, 2019-12-02

• Pediatric Oncology Provider Views on Biopsying Solid Tumors in Children with Relapsed or Refractory Disease for the Purpose of Genomic Profiling, 2016-07-26

• Assessment of Extent of Surgical Resection of Primary High-Grade Osteosarcoma by Treating Institutions: A Report From the Children's Oncology Group, 2016-01-18

• Patient/parent perspectives on genomic tumor profiling of pediatric solid tumors: The Individualized Cancer Therapy (iCat) experience, 2016-07-18

• BRCA1-Associated RING Domain-1 (BARD1) Loss and GBP1 Expression Enhance Sensitivity to DNA Damage in Ewing Sarcoma, 2022-04-20

• Priorities to promote participant engagement in the Participant Engagement and Cancer Genome Sequencing (PE-CGS) Network, 2023-04-03

• Rapid and highly sensitive approach for multiplexed somatic fusion detection, 2022-03-28

• Gene fusions create partner and collateral dependencies essential to cancer cell survival, 2021-06-07

• Adverse prognostic impact of the loss of STAG2 protein expression in patients with newly diagnosed localised Ewing sarcoma: A report from the Children's Oncology Group, 2022-10-11

• Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group, 2018-08-21